Introducing Max Jacobs!?? We’re excited to welcome Max as the newest member of our Commercial Operations team, joining us as a Commercial Data & Reporting Analyst. Having recently earned his Master's degree in Data Science from Rutgers University, he brings a strong foundation in business intelligence and quantitative techniques. Outside of work, you might find Max engaged in a rapid or blitz chess match. He also has a passion for modern and abstract art at museums and exhibitions! Please join us in giving Max a warm welcome!?? #WelcomeToTheTeam #DataScience #NewHire
关于我们
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-licensing them to the world. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies.
- 网站
-
https://www.nspharma.com
NS Pharma, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Paramus,New Jersey
- 类型
- 私人持股
- 创立
- 1999
- 领域
- Hematology、Orphan Diseases、Urology、Gynecology和ENT
地点
-
主要
140 E Ridgewood Ave
US,New Jersey,Paramus,07652
NS Pharma, Inc.员工
动态
-
The 2025 Muscular Dystrophy Association Conference is just around the corner and we can't wait to get involved! This Sunday, our team will be touching down in Dallas for what will be the largest gathering of neuromuscular disease professionals in the US. This huge event brings together clinicians, researchers and industry leaders to share the latest breakthroughs in Duchenne muscular dystrophy and other neuromuscular diseases. With a focus on cutting-edge research, clinical care and collaboration, this is a must-attend event for all those dedicated to improving patient outcomes! We'll be in Dallas from March 16th-19th so be sure to stop by booth #639 to say hello to our team. #Duchenne #Neuromuscular #MuscularDystrophy
-
-
News just in - the FDA has accepted the Biologics License Application (BLA) for deramiocel, an investigational cell therapy for Duchenne cardiomyopathy! This is a significant step forward for the Duchenne community, and we are excited to partner with Capricor Therapeutics, Inc. to bring new hope and potential treatments to patients and their families. Read more about it here: https://ow.ly/rKZO50Vcx5G #Duchenne #DMD #RareDiseases
-
-
Happy Employee Appreciation Day! ?? At NS Pharma, our team is at the heart of everything we do, and today, we’re taking a moment to celebrate your dedication, passion, and hard work. From groundbreaking research to unwavering patient support, each of you plays a vital role in making a difference for the rare disease community. Your commitment does not go unnoticed so as a small token of our appreciation, we’re celebrating with an office party! ?? Thank you for everything you do! ?? #EmployeeAppreciationDay #NSPLife #BestEmployees
-
-
We're delighted to be sponsoring The Akari Foundation's In-Person Workshop this weekend! This free, Spanish-language event is dedicated to supporting the Hispanic Duchenne muscular dystrophy (DMD) community. Families will have the opportunity to connect with experts, enjoy engaging activities for children and share experiences with others navigating the DMD journey. ?? San Diego, California ?? Saturday, March 8 ? 10:00 AM – 4:00 PM Join us for an informative and welcoming space to learn, connect, and support each other. We look forward to seeing you there! ?? #Duchenne #RareDiseases #DuchenneAwareness
-
-
Join us in Louisville this Saturday! Our friends at CureDuchenne will be hosting another wholesome community dinner session this weekend and we'd love to see you there! ?? Location: Mesh, Louisville ?? Date: Saturday, March 8 ? Time: 6:00 PM – 9:00 PM Register here: https://ow.ly/4HlP50Va5kn #DuchenneCommunity #CureDuchenneCares #Duchenne
-
-
We’re proudly wearing our stripes for #RareDiseaseDay!???? At NSP, we stand with the rare disease community not just today, but everyday. From research to advocacy, we’re committed to making a difference for those living with Duchenne and other rare diseases. How great does our team look in their stripes? #WearYourStripes #RareDiseases #Duchenne
-
Exciting news! On March 1st, our friends at CureDuchenne are hosting a full-day workshop in Birmingham - dedicated to enhancing the quality of life for individuals with Duchenne and Becker muscular dystrophy! This interactive event will provide valuable information, resources, and best practices to support our community. Sign up here: https://ow.ly/8ftm50V6L5i #CureDuchenneCares #RareDisease #Duchenne
-
-
Did you know that 300 million people worldwide live with a rare disease? In the U.S. alone, ~15,000 individuals are living with Duchenne muscular dystrophy—a progressive neuromuscular disorder that currently has no cure. But together, we’re working to change that! This year we’re proud to be a sponsor of the Jett Foundation's 2025 Rare Disease Day Event, highlighting incredible community members who are thriving through adaptive experiences and adaptive living—proving that passions have no limits! Join us this Friday for an inspiring panel discussion, moderated by Sean and Kyle of the Two Disabled Dudes Podcast. Register now: https://ow.ly/S7Yq50V5lTN ??Virtual ?? Feb 28, 2025 ? 6:00 PM GMT See you there! #RareDiseases #RareDiseaseDay #Duchenne
-
-
What is exon-skipping therapy? ?? It’s a treatment that helps people with Duchenne make usable dystrophin — a protein their muscles need. By “skipping” a section of the dystrophin gene, it helps the person make usable dystrophin within their own body. Stay tuned for more answers to common Duchenne questions in our FAQ series. ?? #DuchenneAwareness #ExonSkipping #Duchenne
-